L-Serine → (2S)-N-[1-[(1-amino-6-isoquinolinyl)methyl]-2-oxo-2-(1-piperidinyl)ethyl]-3-hydroxy-2-[(2-naphthalenylsulfonyl)amino]propanamide hydrochloride

HRID 1008487

반응식

HRID 1008487 반응식
Cl.[NH2:2][C:3]1[C:12]2[C:7](=[CH:8][C:9]([CH2:13][CH:14]([NH:23][C:24](=[O:45])[CH2:25][NH:26][S:27]([C:30]3[C:31]([CH3:44])=[C:32]([CH3:43])[C:33]4OC(C)(C)[CH2:36][CH2:35][C:34]=4[C:41]=3C)(=[O:29])=[O:28])[C:15](=[O:22])[N:16]3[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]3)=[CH:10][CH:11]=2)[CH:6]=[CH:5][N:4]=1.NC1C2C(=CC(CC(NC(=O)OC(C)(C)C)[C:59](=[O:66])N3CCCCC3)=CC=2)C=CN=1.OC[C@H](NS(C1C=CC2C(=CC=CC=2)C=1)(=O)=O)C(O)=O.N[C@H](C(O)=O)CO.C1C2C(=CC=CC=2)C=CC=1S([Cl:115])(=O)=O>>[ClH:115].[NH2:2][C:3]1[C:12]2[C:7](=[CH:8][C:9]([CH2:13][CH:14]([NH:23][C:24](=[O:45])[C@@H:25]([NH:26][S:27]([C:30]3[CH:31]=[CH:44][C:33]4[C:34](=[CH:35][CH:36]=[CH:43][CH:32]=4)[CH:41]=3)(=[O:29])=[O:28])[CH2:59][OH:66])[C:15](=[O:22])[N:16]3[CH2:21][CH2:20][CH2:19][CH2:18][CH2:17]3)=[CH:10][CH:11]=2)[CH:6]=[CH:5][N:4]=1

참가 물질

6

실험 절차

The procedure described for 5c was used. Deprotection of 5a and coupling with (2S)-3-hydroxy-2-[(2-naphthalenyisulfonyl)amino]propanoic acid (prepared from L-serine and 2-naphthalenylsulfonylchloride using the procedure described for 5b) yielded 7. 1H-NMR 200 MHz (CD3OD) δ: 1.12-1.58 (6H, m), 2.57-2.69 (1H, m) 2.95-3.95 (8H, m), 4.9-5.1 (1H, m), 7.11-7.22 (1H, m), 7.43-8.16 (9H, m), 8.24-8.34 (1H, m), 8.41-8.45 (1H, m).

후처리

  1. customyielded 7

출처 및 근거

ORD 기록
ord-44d0b00bd4054c32942da50141e4bd8d
출처 데이터셋
uspto-grants-2004_09
특허 번호
US06797710B2

연결된 노트

불러오는 중…